Lindy
Fact
News That Stands the Test of Time
Radio
Library
Manifesto
All Stories
Lindy
Breaking
Concepts
Radio
Novo
Lilly
Nordisk
Eli
CagriSema
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
Reuters • 2/23/2026
Summary
No summary yet.
Share:
X
Reddit
LinkedIn
Copy link
Share…
Advertisement
Lindy Score Breakdown (V4.2)
48d
Age
2
Sources
from cluster
1168
Hours Since Seen
Final Score
0/100
Category
AntiLindy
Status
Archived
Recency Multiplier
0%
(0.5^1168/48)
Hero Eligible
No
Score is 0 because recency decay (0.5^1168/48 = 0.000000) reduced it below 0.5
Story Timeline
2026-02-23
Novo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trial
(current)
+1 more source
Analysis
Risk 20
Source Reputation:
Moderate trust (10/20 pts)
Consensus:
Emerging consensus: 2 sources
Age:
48 days - proven survivor
Same Story
from 2 sources
STAT+: Novo Nordisk’s next-gen obesity drug stumbles in comparison study
Stat News • 1+ months
Breaking
Similar stories
Stocks making the biggest moves premarket: Lumentum, ServiceNow, Sandisk & more
CNBC • 2 days ago
Top Century 21 firm expands into Michigan
Housing Wire • 2 days ago
NAR settles Tuccori homebuyer commission case for $52.25M
Housing Wire • 2 days ago
Briefings
The Economist • 1 day ago
Porsche deliveries tumble further in first quarter
Reuters • 2 days ago
Behind China's 'active efforts' for an Iran ceasefire: Business trumps politics
CNBC • 2 days ago
Oil set for largest weekly loss in 10 months after ceasefire
Reuters • 2 days ago
Big screens, bigger fandom: BTS brings ‘ARIRANG’ tour to AMC theaters
Reuters • 1 day ago
German far right pledges migrant deportations and Russian school exchanges
Financial Times • 1 day ago
South Africa’s ANC looks to shore up power as local elections loom
Financial Times • 1 day ago
Anti-Lindy
Similar stories
Americas | Latest news and analysis
The Economist • 1 week ago
World
The Economist • 2+ months
Food
The Economist • 2+ months
Americas | Latest news and analysis
The Economist • 4 weeks ago
World
The Economist • 2+ months
Oil rises as expanding US-Israeli conflict with Iran elevates supply risks
Reuters • 1+ months
Americas | Latest news and analysis
economist.com • 6 days ago
World
The Economist • 2+ months
Americas | Latest news and analysis
The Economist • 4 weeks ago
Leaders
economist.com • 6 days ago
Read the full story on Reuters ↗